Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana

HBsAg-positive patients are at significantly increased risk of adverse clinical outcomes after starting ART. Further studies are warranted to evaluate whether these risks remain now that tenofovir is becoming routinely available in Ghana.